Clock

What this tab establishes

KKR's 49.8% drawdown is a multiple event, not an earnings event: trailing adjusted net income per share rose 2.3% between the January 2025 peak and the March 2026 trough while the multiple paid for it fell roughly half. The clock runs on monetization — converting a near-record $18.3 billion embedded-gain balance into printed carried interest. Five prior NYSE-era drawdowns of 34–58% round-tripped in a median 22.3 months.

The gap, in arithmetic

The starting point for any re-rating question is what actually moved. On 31 January 2025 the shares closed at $167.07; on 12 March 2026 they closed at $83.88, a fall of 49.8% [1]. Over that same span the trailing adjusted-net-income figure the market could see went up: FY2024 adjusted net income was $4.76 per share and FY2025 came in at $4.87 (the four reported quarters sum to $4.86), a gain of 2.3%.

That forces the decomposition. The trailing multiple went from 167.07 ÷ 4.76 = 35.1x at the peak to 83.88 ÷ 4.87 = 17.2x at the trough — a compression of 50.9%. Multiplying the two effects, 1.023 × 0.491 = 0.502, reproduces the 49.8% price fall almost exactly. Nothing in the drawdown is earnings damage. All of it is the price of a dollar of KKR's earnings.

This matters for the clock because the two cases have different repair mechanics. A cut-earnings dislocation re-rates when the earnings come back and the market can see them in a printed quarter. A multiple dislocation re-rates when the market changes what it will pay for a stream that never stopped growing — which no single dated event controls, but which several dated events can inform. The Damage Math tab carries the temporary-versus-permanent question itself; this tab takes the mechanism and the timing.

What has to close the gap

Four mechanisms are identifiable and at least partly evidenced. They are not equally strong, and one commonly cited mechanism — buyback shrinking the denominator — does not carry weight here at the scale involved.

1. Monetization converting embedded gains into printed carry. This is the load-bearing mechanism, and it is the one management itself has put on a quarterly reporting calendar. Total embedded gains — gross accrued carry plus balance-sheet gains — stood at $19 billion at 31 December 2025, described as a record, and at $18.3 billion at 31 March 2026, up 11% year-over-year even after realizations [2] [3]. The conversion is running: first-quarter 2026 realized carried interest was $720 million, up 120% year-on-year, inside roughly $880 million of total monetization revenue [4]. Forward visibility from exits since 31 March plus signed transactions was put at over $1.2 billion of gross monetization revenue — "the largest forward monetization figure we've discussed on a call in our history" [5]. The counter-fact sits in the same paragraph: management simultaneously said the environment four months into 2026 had been "a bit more challenging" than budgeted, and that on the $7-plus adjusted-net-income target "it is more likely that we land below that level," with delayed monetizations expected to shift to 2027 and beyond [6].

2. A one-off charge rolling off. Fourth-quarter 2025 adjusted net income was $1.12 per share; excluding a carried-interest repayment obligation it was $1.30 [7]. The charge reversed compensation paid on roughly $350 million of gross carry collected years earlier from the Asia II fund, cost about $0.18 of quarterly adjusted net income per share, and management stated it did not see any other material clawback risk across the portfolio [8]. This mechanism has already fired: the fourth quarter of 2025 was the only quarter in the last seven to miss consensus, and the following quarter printed $1.39 against a $1.26 estimate.

3. The fee base stepping up mechanically. Committed-but-uncalled capital stood at $125 billion at 31 March 2026, with over 90% of KKR's capital perpetual or committed for eight years or more [9]. Fee-related earnings per share of $1.13 in the first quarter of 2026 were up 23% year-over-year, and management fees up 30% [10]. This is the closest thing here to a contractual repricing calendar: capital already committed begins paying fees as it is called, without a new fundraising decision.

4. A feared event failing to happen. The specific fear priced through February 2026 was private-credit stress. KKR's disclosed exposure: direct lending is $39 billion, or 5% of assets under management; the private business-development-company footprint is around $3 billion, or 0.4%; the public BDC is under 2% [11]. Against $4 billion of K-Series wealth inflows in the quarter, redemptions were about $250 million [12]. A fear this narrowly scoped expires by not materialising, quarter after quarter, rather than by a single event. The counter-fact: management explicitly guided to a wealth-flow slowdown in the second quarter [13], so the second-quarter K-Series number is a genuine test rather than a formality.

The mechanism that does not carry weight here. Repurchases were $317 million through 1 May 2026 at an average of roughly $91, with an additional $500 million authorized [14]. Against roughly 891 million shares, $317 million at $91 retires about 3.5 million shares, or 0.39% of the count; the incremental authorization is a further 0.55% at the current price. Weighted-average basic shares were 891,145,378 in the first quarter of 2026 against 888,246,698 a year earlier — a count that rose, not fell [15]. On the framework's terms a rising share count is a fact against fit, and it is stated here plainly rather than left to the Self-Help tab: the denominator is not the mechanism at this scale.

The catalyst calendar

Sources: Q2 2026 reporting date from the 1 July 2026 scheduling release [16]; prior reporting dates from the run's earnings calendar; Investor Day target progress from the Q4 FY2025 call [17]; consensus figures from the run's estimates feed.

The nearest catalyst is dated and imminent: KKR reports second-quarter 2026 results before market open on 30 July 2026, with a 9:00 a.m. ET call [18]. Consensus is $1.427 of adjusted net income per share against $1.39 printed in the first quarter. Two figures in that release carry more information than the headline: realized carried interest against the $720 million first-quarter run-rate, and the updated forward monetization figure against the $1.2 billion-plus disclosed on 5 May.

The 2026 guidance framework itself expires with the year. The $4.50-plus fee-related-earnings and $7-to-$8 adjusted-net-income targets for 2026 were set in November 2023 and November 2021 respectively [19]; the $300 billion-plus fundraising target covers 2024 through 2026 and was over 80% complete at $240 billion as of February 2026 [20]. A successor medium-term framework has not been announced, so it is listed above as a window closing rather than as a scheduled event.

Base rates from KKR's own history

KKR's common stock has traded on the NYSE since 15 July 2010; the daily series in this run runs from 11 January 2007 to 28 July 2026 across 4,737 sessions [21], with the pre-July-2010 leg reflecting the predecessor Euronext-listed vehicle rather than the NYSE common. The base rates below are computed on the NYSE era, on closing prices, without dividend adjustment — KKR's annualized dividend of $0.78 is roughly 0.8% of the current price, so reinvestment shifts the recovery dates by weeks, not quarters [22].

An episode is defined as a peak-to-trough decline of 25% or more on closing prices, measured from a running maximum and closed when the price regains that maximum. Five such episodes completed between July 2010 and the current one.

Source: derived from the run's daily closing-price series, 15 July 2010 to 28 July 2026 [23]. Depth = 1 minus (trough close divided by peak close).

Source: derived from the run's daily closing-price series [24]. Months = calendar days divided by 30.44.

Source: derived from the run's daily closing-price series [25]. Peak and trough dates: 29 Apr 2011 to 3 Oct 2011, recovered 8 Mar 2013; 22 Jan 2014 to 11 Feb 2016, recovered 3 Jul 2018; 24 Sep 2018 to 24 Dec 2018, recovered 16 Sep 2019; 19 Feb 2020 to 23 Mar 2020, recovered 9 Jul 2020; 3 Nov 2021 to 30 Sep 2022, recovered 15 Dec 2023; 31 Jan 2025 to 12 Mar 2026, not recovered.

The arithmetic a skeptic can recompute: 1 − (9.92 ÷ 18.96) = 47.7%; 1 − (11.13 ÷ 26.30) = 57.7%; 1 − (18.68 ÷ 28.25) = 33.9%; 1 − (18.50 ÷ 33.93) = 45.5%; 1 − (43.00 ÷ 83.40) = 48.4%; 1 − (83.88 ÷ 167.07) = 49.8%. Median depth of the five completed episodes is 47.7%. Median time from trough back to the prior peak is 14.5 months; median round trip from peak to recovered peak is 22.3 months. The current episode is the second-deepest of the six and took 13.3 months to reach its low — longer than four of the five precedents.

The 2007–09 episode belongs in the record but not in the base rate. From $31.31 on 1 March 2007 the price fell 93.7% to $1.96 on 24 February 2009 and did not regain $31.31 until 22 January 2020 — 130.9 months past the trough. That series is the Euronext-listed predecessor vehicle before the NYSE listing, at a different scale, capital structure and business mix, and treating it as a precedent for the listed KKR common would overstate what this name's own history says.

As of the 28 July 2026 close of $102.66, the current episode sits 138 days — 4.5 months — past its trough, 22.4% above the low and 38.6% below the peak. Regaining $167.07 from here requires a further 62.7%.

The 18-month read

Re-recognition inside roughly 18 to 24 months is a reasonable expectation on this evidence, and the reason is that the path does not require cycle repair. The earnings never broke: fee-related earnings per share, total operating earnings and adjusted net income all grew about 20% year-over-year in the first quarter of 2026 [26], 2025 was a record fundraising year at $129 billion [27], and the gap the price has to close is the multiple. The base rates say this name has closed 34%-to-58% gaps four times out of five within 25.4 months of the peak. Measured from the 12 March 2026 trough, a window running 18 months from today reaches 22.6 months past the trough, which covers four of the five precedents; extending it to 24 months reaches 28.6 months past the trough, still one month short of the slowest case — the 2014–16 episode at 28.7 months.

The strongest fact against the read is that the mechanism has already slipped once. The $7-plus 2026 adjusted-net-income target was affirmed on 5 February 2026 [28] and walked back on 5 May 2026, three months later [29]. Monetization timing is the variable, and it is the variable management controls least. A second slip would push the printed inflection from 2027 into 2028 and put the recovery outside the window.

What would falsify the read, tied to the falsifier ledger: realized carried interest and the disclosed forward monetization figure both declining across the 30 July 2026, late-2026 and early-February 2027 prints, against the $720 million and $1.2 billion baselines set on 5 May 2026; or fee-related earnings per share growth dropping out of the high-teens range that has held for three years. Either would mean the mechanism is not firing, at which point the base rates cease to be the right reference and the 2014–16 case becomes the relevant precedent.

What consensus expects, and when

The sell side has not capitulated. The run's estimates summary carries 21 ratings — 6 strong buy, 12 buy, 3 hold, and none at sell or strong sell — with a mean price target of $123.48 [30]. The run's consensus feed shows the same picture on a broker-scale taxonomy: 12 buy, 7 outperform, 3 hold, none negative, for a consensus recommendation score of 1.59 where 1 is buy and 5 is sell, and a target distribution of $122 median, $147 high and $105 low across twenty published targets.

Sources: close from the run's daily price series [31]; mean target and rating mix from the run's analyst estimates summary [32]; target dispersion from the run's consensus feed.

Two readings of that positioning both deserve stating. The lowest target on the street, $105, sits 2.3% above the last close — after a 49.8% decline, not one of twenty published targets implies downside. On the framework's fear gauge that is the opposite of capitulation, and it is a fact against the setup. On the framework's consensus rule it is the supportive configuration: the sell side still underwrites the earnings, and it is the buy side that has sold. The two readings cannot both be resolved here; the drawdown's ownership and volume evidence sits in Dislocation.

What the targets imply about multiple is more informative than the level. The mean target of $123.48 against FY2027 consensus adjusted earnings of $7.35 per share is 16.80x. The current price of $102.66 against FY2026 consensus of $6.12 is 16.78x. The street's twelve-month target is today's multiple rolled onto next year's earnings — it embeds no re-rating at all. The most bullish target on the tape, $147, is still 12% below the January 2025 peak.

Source: reported figures and consensus means from the run's estimates and earnings-calendar feeds; the 4Q25 reported figure of $1.12 includes the carried-interest repayment obligation and is $1.30 excluding it [33].

Consensus locates the recovery precisely. The annual path runs $4.87 actual for FY2025, $6.12 for FY2026 on 22 estimates, $7.35 for FY2027 on 22 estimates, and $8.60 for FY2028 on 10. Quarterly, the estimates step from $1.427 for the second quarter of 2026 to $1.589 for the third and $1.699 for the fourth. The candidate quarter is the fourth quarter of 2026, reported in early February 2027: it is the first quarter in which consensus has KKR printing an adjusted-net-income run-rate of roughly $6.80 annualized — the level the withdrawn $7-plus guidance implied, arriving four quarters late, and the first print at which the 2026 shortfall becomes a completed fact rather than an open question. The nearer prints on 30 July 2026 and in late 2026 are tests of whether that path is intact, not the re-rating event itself.

The gap between consensus and the March 2026 trough is worth one line of arithmetic. At the $83.88 low, the FY2027 consensus of $7.35 was being capitalized at 11.4x. At $102.66 it is 14.0x. Both sit well below the 35.1x trailing multiple carried at the January 2025 peak.

The instrument facts

These are facts about listed instruments, stated as facts. No structure, strike, expiry or sizing is suggested anywhere in this report.

Long-dated listed options exist on KKR. As of the 28 July 2026 close, the listed option chain extended to a 21 January 2028 expiration — 541 calendar days, or about 17.8 months, beyond that close — with a 17 December 2027 series also listed at 506 days, or about 16.6 months. Intermediate series were listed for 15 January 2027, 19 March 2027, 21 May 2027 and 17 June 2027 (Stock Options Channel and Public.com option chains, retrieved 29 July 2026, both showing the $102.66 reference price). Expiries beyond twelve months are therefore available; the longest listed expiry falls just under eighteen months.

Implied volatility. KKR's 30-day mean implied volatility was 41.5% as of 28 July 2026 — 40.4% on calls, 42.5% on puts — against 30-day close-to-close historical volatility of 32.5% (AlphaQuery KKR volatility statistics, data date 28 July 2026). Against the framework's reference lines, where up to roughly 50–55 is treated as acceptable and 60–70 as elevated, 41.5% sits inside the acceptable band. This is the 30-day measure; the implied volatility of the January 2028 series specifically was not verifiable from available sources.

Liquidity. KKR is an S&P 500 constituent with a multi-exchange listed option market. On the 28 July 2026 session, 6,668 call contracts and 1,805 put contracts traded against 3.40 million shares (Stock Options Channel, retrieved 29 July 2026). Open interest is concentrated in the near-dated series; a contract-level open-interest tally for the December 2027 and January 2028 expirations was not verifiable from available sources.

Because listed options with expiries beyond twelve months do exist here, the framework's watchlist-only consequence — the case where no qualifying long-dated instrument is available — does not apply to this name.